Please use this identifier to cite or link to this item: http://repositorio.cedes.org/handle/123456789/4478
Título : Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries
Autor : Butera, Nicole 
de Sanjose, Sylvia 
Hoyt, Alexis M 
Morgan, Karen 
McDonald, Mary Anne 
Senkomago, Virginia 
Islam, Jessica Yasmine 
Smith, Jennifer S 
Ramos, Silvina 
Kim, Chan Joo 
Richter, Karin L 
Vielot, Nadja A 
Palabras clave : VACUNA CONTRA HPV;VACUNAS CONTRA PAPILLOMAVIRUS;Adolescentes
Fecha de publicación : Nov-2018
Editorial : 1573-7225
Resumen : PURPOSE: The World Health Organization revised its human papillomavirus (HPV) vaccination recommendations to include a two (2-) dose schedule for girls aged ≤ 15 years. We investigated acceptability of 2- versus 3-dose schedule among adolescent vaccination providers and mothers of adolescent girls in five countries. METHODS: Adolescent vaccination providers (N = 151) and mothers of adolescent girls aged 9-14 years (N = 118) were recruited from Argentina, Malaysia, South Africa, South Korea, and Spain. We assessed providers' preference for a 2- versus 3-dose HPV vaccination schedule via quantitative surveys. Mothers' attitudes towards a 2-dose schedule were assessed through focus group discussions. RESULTS: Most adolescent providers preferred a 2- over a 3-dose HPV vaccination schedule (overall: 74%), with preference ranging from 45.2% (South Africa) to 90.0% (South Korea). Lower cost, fewer clinic visits, and higher series completion were commonly cited reasons for 2-dose preference among providers and mothers. Safety and efficacy concerns were commonly cited barriers to accepting a 2-dose HPV vaccination schedule among providers and mothers. Mothers generally accepted the reduced schedule, however requested further information from a trusted source. CONCLUSIONS: Adolescent vaccination providers and mothers preferred the 2-dose over 3-dose HPV vaccination schedule. Acceptability of a 2-dose HPV vaccination could be improved with additional information to providers and mothers on HPV vaccination safety and efficacy.
URI : https://link.springer.com/article/10.1007%2Fs10552-018-1085-1
http://repositorio.cedes.org/handle/123456789/4478
DOI: 1573-7225
11
1115-1130
29
10.1007/s10552-018-1085-1
Appears in Collections:Artículos en publicaciones periódicas

Show full item record

Page view(s)

13
checked on Sep 17, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.